Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

European Stock Futures Lower; Caution as ECB Meeting Looms

Published 03/10/2021, 02:00 AM
Updated 03/10/2021, 02:01 AM
© Reuters.

By Peter Nurse 

Investing.com - European stock markets are seen opening lower Wednesday, struggling to maintain the momentum seen on Wall Street overnight amid worries of a slowing economic recovery.

At 2:05 AM ET (0705 GMT), the DAX futures contract in Germany traded 0.3% lower, CAC 40 futures in France dropped 0.3% and the FTSE 100 futures contract in the U.K. fell 0.8%.

On Tuesday, the tech-heavy Nasdaq Composite climbed 3.7% to post its best day on Wall Street since November, as investors poured back into popular growth names after a recent pullback. 

However, this surge has failed to translate into any serious gains in Asia, with Chinese shares marginally higher after they had fallen to their lowest levels since mid-December the previous day, while in Europe the tone is one of caution ahead of Thursday’s meeting of the European Central Bank.

Eurozone quarterly GDP was revised down to -0.7% in the fourth quarter on Tuesday from the preliminary reading of -0.6% despite stronger growth from Germany, as the lockdowns across the euro area weighed on growth.

Although there are hopes that these lockdowns will be eased soon, the region will in all likelihood register a technical recession when the first quarter GDP figures are released. This puts pressure on the ECB, particularly with European bond yields edging higher, potentially resulting in tightening financial conditions.

Adding to concerns is a diplomatic spat between the U.K. and the European Union after Charles Michel, the president of the European Council, claimed the U.K. had banned all Covid-19 vaccine exports, something vehemently denied by the British government.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

EU leaders have been under pressure over the slow rollout of Covid-19 vaccines on the continent, compared with the UK, where a third of the adult population have now received their first dose.

Elsewhere, the U.S. House of Representatives is likely to pass the $1.9 trillion Covid relief bill later Wednesday, allowing President Joe Biden to sign it into law by the weekend.

In corporate news, German sportswear maker Adidas (OTC:ADDYY) has predicted a strong rebound in sales in 2021, particularly in China, although its operating profit will be trimmed by costs associated with divesting the Reebok brand.

Earnings also come from the likes of fashion group Inditex (MC:ITX), sanitary products manufacturer Geberit (SIX:GEBN), security services group G4S (CSE:G4S) and construction group Balfour Beatty (OTC:BAFYY). 

Oil prices weakened Wednesday, falling back from recent highs after an industry report showed a jump in U.S. oil stocks last week.

Crude inventories rose by 12.8 million barrels in the week to March 5, according to data from the American Petroleum Institute. Official figures from the Energy Information Administration are expected later Wednesday.

U.S. crude futures traded 1% lower at $63.36 a barrel, while the international benchmark Brent contract fell 1.1% to $66.77.  

Elsewhere, gold futures fell 0.3% to $1,712.35/oz, while EUR/USD traded 0.2% lower at 1.1875.

 

Latest comments

Trash news
sounds great!
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.